123 related articles for article (PubMed ID: 475431)
1. Cushing's disease presenting with growth failure: clinical remission during cyproheptadine therapy.
Grant DB; Atherden SM
Arch Dis Child; 1979 Jun; 54(6):466-8. PubMed ID: 475431
[TBL] [Abstract][Full Text] [Related]
2. Cyproheptadine may act at the pituitary in Cushing's disease: evidence from CRF stimulation.
Tucci JR; Nowakowski KJ; Jackson IM
J Endocrinol Invest; 1989 Mar; 12(3):197-200. PubMed ID: 2542391
[TBL] [Abstract][Full Text] [Related]
3. Cyproheptadine treatment in Cushing's disease.
Tanakol R; Alagöl F; Azizlerli H; Sandalci O; Terzioğlu T; Berker F
J Endocrinol Invest; 1996 Apr; 19(4):242-7. PubMed ID: 8862505
[TBL] [Abstract][Full Text] [Related]
4. [Use of cyproheptadine in the treatment of Cushing's disease].
Jannì A; Carmina E; Lanzara P; Lo Coco R; Longo RA
Clin Ter; 1979 Feb; 88(4):345-54. PubMed ID: 222530
[No Abstract] [Full Text] [Related]
5. Sodium valproate and cyproheptadine may independently induce a remission in the same patient with Cushing's disease.
Koppeschaar HP; Croughs RJ; Thijssen JH; Schwarz F
Acta Endocrinol (Copenh); 1983 Oct; 104(2):160-3. PubMed ID: 6314723
[TBL] [Abstract][Full Text] [Related]
6. Rebound elevation of cortisol following cyproheptadine withdrawal in Cushing's disease from a pituitary macroadenoma.
Ooi TC; Twum-Barima Y
J Endocrinol Invest; 1987 Apr; 10(2):107-9. PubMed ID: 3584851
[TBL] [Abstract][Full Text] [Related]
7. Effect of the antiserotonin drug, cyproheptadine, on plasma beta-endorphin and beta-lipotropin in patients with Itsenko-Cushing's disease.
Slavnov VN; Valueva GV; Luchitsky EV
Exp Clin Endocrinol; 1985 Jun; 85(3):341-50. PubMed ID: 2995088
[TBL] [Abstract][Full Text] [Related]
8. Cyproheptadine-induced remission of Cushing's disease due to pituitary basophil adenoma.
Jimenez-Alonso J; Munoz-Avila J; Jaimez L; Pérez-Jimenez F; Bellido C; Jiménez-Perepérez JA
Drug Intell Clin Pharm; 1982 Dec; 16(12):962-5. PubMed ID: 6295736
[TBL] [Abstract][Full Text] [Related]
9. Two pregnancies in a woman with Cushing's syndrome treated with cyproheptadine. Case report.
Kasperlik-Załuska A; Migdalska B; Hartwig W; Wilczyńska J; Marianowski L; Stopińska-Głuszak U; Lozińska D
Br J Obstet Gynaecol; 1980 Dec; 87(12):1171-3. PubMed ID: 7437385
[TBL] [Abstract][Full Text] [Related]
10. [Transitory remission of hypercorticism by means of cyproheptadine in a patient with Cushing syndrome].
Vetter W; Vetter H; Beckerhoff R; Würsten D; Siegenthaler W
Schweiz Med Wochenschr; 1976 Sep; 106(39):1320-2. PubMed ID: 1034340
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome.
Ambrosi B; Gaggini M; Secchi F; Faglia G
Horm Metab Res; 1979 Apr; 11(4):318-9. PubMed ID: 222663
[No Abstract] [Full Text] [Related]
12. Cyproheptadine in the control of Cushing's disease.
Hsu TH; Gann DS; Tsan KW; Russell RP
Johns Hopkins Med J; 1981 Aug; 149(2):77-83. PubMed ID: 6265685
[TBL] [Abstract][Full Text] [Related]
13. Cushing's disease: Successful treatment with cyproheptadine.
Barnes P; Shaw K; Ross E
Lancet; 1977 May; 1(8022):1148-9. PubMed ID: 68240
[No Abstract] [Full Text] [Related]
14. Cortisol secretory patterns in Cushing's disease and response to cyproheptadine treatment.
van Waveren Hogervorst CO; Koppeschaar HP; Zelissen PM; Lips CJ; Garcia BM
J Clin Endocrinol Metab; 1996 Feb; 81(2):652-5. PubMed ID: 8636284
[TBL] [Abstract][Full Text] [Related]
15. [Effect of cyproheptadine on plasma ACTH and cortisol secretion in a patient with Cushing's disease].
Esposito V; D'Alessandro B; Bellastella A; Iacono G; Bizzarro A; Officioso A; Piccolo C
Boll Soc Ital Biol Sper; 1976 Nov; 52(22):1901-5. PubMed ID: 194608
[No Abstract] [Full Text] [Related]
16. Cushing's disease: failure of treatment with cyproheptadine.
Allgrove J; Husband P; Brook CG
Br Med J; 1977 Mar; 1(6062):686-7. PubMed ID: 843872
[No Abstract] [Full Text] [Related]
17. [Dynamics of beta-lipotropin and beta-endorphin levels in Itsenko-Cushing disease patients being treated with the antiserotonin preparation cyproheptadine (peritol) and chloditan].
Slavnov VN; Valueva GV; Luchitskiĭ EV
Ter Arkh; 1984; 56(9):119-22. PubMed ID: 6096979
[TBL] [Abstract][Full Text] [Related]
18. Response to neurotransmitter modulating drugs in patients with Cushing's disease.
Koppeschaar HP; Croughs RJ; Thijssen JH; Schwarz F
Clin Endocrinol (Oxf); 1986 Dec; 25(6):661-7. PubMed ID: 3115630
[TBL] [Abstract][Full Text] [Related]
19. Prolonged remission of a case of Cushing's disease following cessation of cyproheptadine therapy.
Wiesen M; Ross F; Krieger DT
Acta Endocrinol (Copenh); 1983 Mar; 102(3):436-8. PubMed ID: 6829265
[No Abstract] [Full Text] [Related]
20. Five cases of cyclical Cushing's syndrome.
Atkinson AB; Kennedy AL; Carson DJ; Hadden DR; Weaver JA; Sheridan B
Br Med J (Clin Res Ed); 1985 Nov; 291(6507):1453-7. PubMed ID: 2998540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
